天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> CAS DataBase List >>Olokizumab

Olokizumab

CAS No.
1007223-17-7
Chemical Name:
Olokizumab
Synonyms
Olokizumab;Olokizumab (anti-IL-6);Research Grade Olokizumab;Research Grade Olokizumab(DHC15804)
CBNumber:
CB48080820
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Last updated:2025-04-18 09:52:21

Olokizumab Properties

form Liquid
color Colorless to light yellow
FDA UNII PAI71R1D2W

Olokizumab Chemical Properties,Uses,Production

Uses

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA)[1].

IC 50

IL-6

References

[1] Kretsos K, et, al. Model-Based Optimal Design and Execution of the First-Inpatient Trial of the Anti-IL-6, Olokizumab. CPT Pharmacometrics Syst Pharmacol. 2014 Jun 18;3(6):e119. DOI:10.1038/psp.2014.17

Olokizumab Preparation Products And Raw materials

Raw materials

Preparation Products

Olokizumab Suppliers

Global( 17)Suppliers
Supplier Tel Email Country ProdList Advantage
Aladdin Scientific
tp@aladdinsci.com United States 57505 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903 3008007409@qq.com China 71826 60
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8010 62
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1566 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10308 58
Bide Pharmatech Ltd. 400-1647117 13681763483 product02@bidepharm.com China 62321 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24884 58
Biolab Reagents 18108604356 18108604356 info@biolabreagent.com China 9868 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 6181 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11973 58
Olokizumab Research Grade Olokizumab(DHC15804) Olokizumab (anti-IL-6) Research Grade Olokizumab 1007223-17-7